Literature DB >> 1837143

A protein kinase is present in a complex with adenovirus E1A proteins.

T Kleinberger1, T Shenk.   

Abstract

A kinase activity can be immunoprecipitated in a complex that includes adenovirus E1A proteins. In vitro, this activity phosphorylated other E1A-associated proteins, as well as added E1A and histone H1 proteins. The E1A-associated kinase activity was cleared from extracts with an antibody to cyclin A, but not with antibody to cyclin B. The formation of a complex that included the kinase activity required amino acids 30-60 and 122-129 on the E1A proteins, sequences needed for association of E1A proteins with cyclin A and the retinoblastoma protein and implicated in control of cell growth. The complex of E1A-associated proteins included a 33-kDa ATP-binding protein, similar in size to a cyclin A-associated cdc2 kinase family member. Sucrose gradient analysis revealed two distinct E1A-containing complexes with the kinase activity. We suggest that E1A proteins may affect cellular proliferation by interacting with a member of the cdc2 kinase family and thereby influencing its activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837143      PMCID: PMC53090          DOI: 10.1073/pnas.88.24.11143

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Association of adenovirus early-region 1A proteins with cellular polypeptides.

Authors:  E Harlow; P Whyte; B R Franza; C Schley
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 2.  p34cdc2: the S and M kinase?

Authors:  J Pines; T Hunter
Journal:  New Biol       Date:  1990-05

3.  Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments.

Authors:  M L Tremblay; C J McGlade; G E Gerber; P E Branton
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

4.  Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement.

Authors:  G Draetta; D Beach
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

5.  Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene.

Authors:  B Moran; B Zerler
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

6.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5.

Authors:  C Egan; T N Jelsma; J A Howe; S T Bayley; B Ferguson; P E Branton
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

8.  The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis.

Authors:  W G Dunphy; L Brizuela; D Beach; J Newport
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

9.  Genetic mapping of a major site of phosphorylation in adenovirus type 2 E1A proteins.

Authors:  A S Tsukamoto; A Ponticelli; A J Berk; R B Gaynor
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

10.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.

Authors:  B T Lin; S Gruenwald; A O Morla; W H Lee; J Y Wang
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  13 in total

1.  Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation.

Authors:  R W Gedrich; S T Bayley; D A Engel
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1.

Authors:  U Müller; T Kleinberger; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  UL34, the target of the herpes simplex virus U(S)3 protein kinase, is a membrane protein which in its unphosphorylated state associates with novel phosphoproteins.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Association of p300 and CBP with simian virus 40 large T antigen.

Authors:  R Eckner; J W Ludlow; N L Lill; E Oldread; Z Arany; N Modjtahedi; J A DeCaprio; D M Livingston; J A Morgan
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.

Authors:  A Mal; A Piotrkowski; M L Harter
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.

Authors:  B M Pützer; H Rumpf; S Rega; D Brockmann; H Esche
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.

Authors:  B Faha; E Harlow; E Lees
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

10.  Multiple domains in the 50 kDa form of E4F1 regulate promoter-specific repression and E1A trans-activation.

Authors:  Robert J Rooney
Journal:  Gene       Date:  2020-06-11       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.